U.S. market Open. Closes in 4 hours 49 minutes

CVAC | CureVac N.V. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
Revenue52.66M67.42M102.99M48.90M17.42M12.87M
Cost of Revenue143.74M183.99M238.19M14.17M27.98M17.74M
Gross Profit-91.08M-116.57M-135.21M34.73M-10.57M-4.87M
Operating Expenses185.14M134.28M277.06M158.70M88.93M67.95M
Selling, General & Admin80.15M89.41M88.94M45.76M43.94M21.50M
Research & Development104.99M62.55M815.91M113.81M43.24M41.72M
Other Operating Expenses-1.00-17.68M-627.79M-870.00K1.75M4.73M
Operating Income-276.22M-249.46M-412.26M-124.00M-99.50M-72.82M
Other Expenses / Income21.58M302.00K-235.00K-5.80M-627.00K1.69M
Before Tax Income-254.64M-249.16M-412.50M-129.80M-100.12M-71.13M
Income Tax Expenses193.94K-126.00K-782.00K-726.00K-252.00K110.00K
Net Income-254.83M-249.03M-411.72M-129.07M-99.87M-71.24M
Interest Expenses2.49M3.71M10.34M22.10M1.46M275.00K
Basic Shares Outstanding220.83M189.07M186.01M132.20M186.91M175.97M
Diluted Shares Outstanding220.83M189.07M186.01M132.20M186.91M175.97M
EBITDA-249.55M-223.10M-386.49M-109.80M-91.50M-67.08M
EBITDA Margin-473.93%-330.91%-375.27%-224.54%-525.38%-521.13%
EBIT-252.15M-245.45M-402.16M-107.70M-98.67M-70.86M
EBIT Margin-478.86%-364.06%-390.48%-220.24%-566.52%-550.51%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙